OMT as an Adjunctive Treatment in MDD

Completed · Not applicable

Conditions studied: Major Depressive Disorder

In brief

participants will be receiving OMT 1x/week for 8 weeks. Each appointment with be a duration of 30 minutes. Patients will be required to fill out PHQ-9 and SSS-8 questionnaires before beginning the study and following the conclusion of the study.

Key facts

Study ID

NCT05065580

Run by

Corewell Health South

People needed

25

Starts

2021-03-12

Expected to finish

2023-03-23

Last updated by the study team

2025-12-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients 18-65, patients with diagnosis of MDD, PHQ-9 score > 10 at screening and baseline

You may not qualify if…

• history of mania, hypomania, or psychosis as defined in DSM V
• current substance abuse, including abuse within the previous 6 months
• patients with a cognitive disorder or dementia
• patients with other axis I diagnosis (anxiety disorders, dissociative disorders, etc.) that was primary in the past 6 months
• receiving other forms of manual therapy during study
• authors belief that there was significant suicidal risk
• changes in medication or psychotherapy within 6 weeks of starting study or during study period
• history of migraines
• presence of any other significant organic disease (infectious, cardiac, pulmonary, gastrointestinal, renal, etc.)
• other absolute contraindications to OMT (malignancy, infection, myelopathy, severe osteoporosis, increased ICP, intracranial bleeding, fractures, etc.)

Where it is running

• Lakeland Regional Healthcare — Saint Joseph, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.